APA (7th ed.) Citation

Slaninová, V., Heron-Milhavet, L., Robin, M., Jeanson, L., Aissanou, A., Kantar, D., . . . Djiane, A. (2024). The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells. BMC Cancer, 24(1), 1. https://doi.org/10.1186/s12885-024-12316-4

Chicago Style (17th ed.) Citation

Slaninová, Věra, et al. "The Hippo Pathway Terminal Effector TAZ/WWTR1 Mediates Oxaliplatin Sensitivity in P53 Proficient Colon Cancer Cells." BMC Cancer 24, no. 1 (2024): 1. https://doi.org/10.1186/s12885-024-12316-4.

MLA (9th ed.) Citation

Slaninová, Věra, et al. "The Hippo Pathway Terminal Effector TAZ/WWTR1 Mediates Oxaliplatin Sensitivity in P53 Proficient Colon Cancer Cells." BMC Cancer, vol. 24, no. 1, 2024, p. 1, https://doi.org/10.1186/s12885-024-12316-4.